Stem Cell Isolation From Femoral Heads Post Total Hip Arthroplasty

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorDavid Hess

About this trial

Femoral heads will be collected at University Hospital (London, ON, Canada) from individuals with type-2 diabetes, obesity, and no T2D/no obesity controls. The femoral head will be taken to the Robarts Research Institute (London, ON, Canada) for lineage-restricted progenitor cell expansion and analyses. There the femoral heads will be used to isolate three stem cell types - Multipotent Stromal Cells, Endothelial Colony Forming Cells, and Hematopoietic Progenitor Cells. The yield and cell surface markers expressed on these cells will be measured using flow cytometry. These cell types will then undergo further analyses of the secretome, tubule forming assays, vascular regenerative cell exhaustion assays, and will be transplanted into immune deficient mice with with femoral artery ligation. These experiments are to assess the differences in function and expression of these cell types between individuals with type-2 diabetes and/or obesity and/or healthy controls.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Must be 18+ years of age

Disqualifiers

Diagnosis of bone cancers

Diagnosis of Rheumatoid arthritis

Diagnosis of hematopoietic conditions

Diagnosis of avascular necrosis of the hip

Trial design

Design model

Parallel

Treatments tested in this trial

  • Hip Replacement

    Procedure/Surgery

    Total Hip Arthroplasty where the Femoral Head will be used to harvest stem cells post-extrication from the individual.

Treatment groups

30 Participants
are divided into 3 treatment groups
Group A: Type-2 DiabetesExperimental treatment 1 intervention
Group B: ObesityExperimental treatment 1 intervention
Group C: Non-Type-2 Diabetic and Non-Obese ControlsExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Cell Yield

Quantification of how many cells are harvested from each femoral head prior to expansion in vitro

Time frame
Within 24 hours of surgery
2

Cellular Growth Kinetics

Quantification of the Growth Kinetics of each cell type during in vitro cell culture post cell harvest.

Time frame
Time of cell harvest to 8 weeks post harvest
3

Cellular Phenotype

Analysis via flow cytometry of the phenotype of each cell type and their respective surface markers that are involved in regenerative pathways.

Time frame
Time of cell harvest to 8 weeks post harvest

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

David Hess

Lead sponsor

Western University, Canada

Sponsor institution

This trial is not recruiting at the moment. You can still explore other options: